LAPACT Trademark

Trademark Overview

On Thursday, April 16, 2015, a trademark application was filed for LAPACT with the United States Patent and Trademark Office. The USPTO has given the LAPACT trademark a serial number of 86599639. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 2, 2022. This trademark is owned by Celgene Corporation. The LAPACT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others on the safety and effectiveness of drugs; conducting clinical trials for others on the safety and effectiveness of drugs to treat pancreatic adenocarcinoma; providing medical and scientific research information in the field of clinical trials
lapact

General Information

Serial Number86599639
Word MarkLAPACT
Filing DateThursday, April 16, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 2, 2022
Registration Number4961458
Registration DateTuesday, May 17, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2015

Trademark Statements

Pseudo MarkLAP ACT
Goods and ServicesConducting clinical trials for others on the safety and effectiveness of drugs; conducting clinical trials for others on the safety and effectiveness of drugs to treat pancreatic adenocarcinoma; providing medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 2, 2022
Primary Code042
First Use Anywhere DateFriday, November 14, 2014
First Use In Commerce DateFriday, November 14, 2014

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, December 2, 2022CANCELLED SEC. 8 (6-YR)
Monday, May 17, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 17, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, April 12, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 11, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 16, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 16, 2015NON-FINAL ACTION E-MAILED
Monday, November 16, 2015SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 21, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 6, 2015USE AMENDMENT FILED
Friday, October 16, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 6, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, October 6, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2015PUBLISHED FOR OPPOSITION
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 8, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 8, 2015ASSIGNED TO LIE
Monday, June 22, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 22, 2015ASSIGNED TO EXAMINER
Friday, April 24, 2015NOTICE OF PSEUDO MARK E-MAILED
Thursday, April 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 20, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

lapact trials clinical conducting drugs effectiveness safety others research information field